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Abstract:  The  feasibility  of  photoacoustic  tomography  (PAT)  for 
noninvasive imaging of prostate cancer was explored through the study on a 
canine  model  in  vivo.  Imaging  of  blood-rich  lesions  mimicking  prostate 
tumors was achieved using a commercial medical ultrasound (US) system 
without  affecting  its  original  imaging  functions.  Based  on  the  optical 
contrast between hemoglobin and other tissues, PAT has demonstrated good 
sensitivity and high contrast-to-noise ratio in visualizing deep lesions; while 
US has presented the morphological features including the boundary and the 
urethral of  the  prostate. PAT  of prostate cancer  may  facilitate  improved 
tumor localization, staging of disease, and detection of recurrences. 
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1. Introduction 
In North America, prostate cancer is the most common noncutaneous malignancy affecting 
men and has the highest mortality rate after lung cancer [1]. Current screening techniques, 
including digital rectal examination (DRE) and the measurement of prostate specific antigen 
(PSA)  levels  in  the  blood,  do  not  adequately  provide  the  information  needed  to  make 
treatment  decisions  [2].  Diagnosis  of  prostate  cancer  remains  dependent  upon  histologic 
assessment of cancer from tissue biopsies. Ultrasonography of the prostate remains the first 
choice of imaging to visualize the prostate. However, gray-scale ultrasound imaging has an 
accuracy  of  about  50-60%  for  the  detection  of  prostate  cancer  and  transrectal  ultrasound 
(TRUS)  used  for  local  grading  has  an  even  lower  accuracy  [3–5].  Because  other  disease 
processes  such  as  benign  prostatic  hyperplasia  (BPH)  and  prostatitis  may  have  a  similar 
appearance to prostate cancer, it is difficult to reliably differentiate these lesions from prostate 
cancer  based  on  sonographic  characteristics  alone.  Despite  the  recent  development  in 
sonographic vascular imaging (e.g. color and power Doppler, and introduction of ultrasound 
contrast agents), TRUS is still confined to the guidance of prostate biopsy. Although TRUS 
by  itself  has  limited  sensitivity  and  specificity  in  the  detection of  prostate  cancer,  TRUS 
images combined with other types of imaging data could improve tumor localization, staging 
of disease, and detection of recurrences [6]. The modest success of color Doppler and contrast 
enhanced ultrasound [7,8] suggest that the improved detection by PAT of tissue blood volume 
and state of oxygenation, discussed below, could yield unique clinical utility of PAT. 
Adaptation  of  novel  optical  modalities  to  cancer  imaging  is  highly  desirable  because 
nonionizing optical signal is sensitive to the molecular conformation of biological tissues and 
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unique advantages, optical imaging should contribute to more accurate characterization of 
prostate  cancer  through  the  synthesis  of  anatomic,  functional,  and  molecular  imaging 
information [9]. It has been reported that near-infrared spectroscopy (NIRS) can been used to 
differentiate cancerous tissues and normal tissues in prostates based on their different spectral 
fingerprint absorption [10]. Optical coherence tomography (OCT) has also been adapted to 
prostate cancer and has demonstrated potential in monitoring the dynamic process of laser and 
radiofrequency ablation [11] and in identifying benign and malignant microscopic structures 
in the prostate gland [12]. More recently, the feasibility of transrectal optical tomography of 
the prostate using an endorectal near-infrared (NIR) applicator integrated with a TRUS probe 
has been investigated [13,14]. Diffuse optical imaging of prostate, however, has only limited 
resolution  because  of  the  strong  photon  diffusion  in  biological  tissues,  which  drastically 
hinders the clinical application of optical imaging in prostate cancer detection and evaluation. 
OCT,  although  delivering  excellent  spatial  resolution,  has  only  limited  penetration  in 
biological tissue and, hence, cannot evaluate a prostate noninvasively as a whole organ. 
Photoacoustic  tomography  (PAT),  also  referred  to  as  optoacoustic  tomography,  is  an 
emerging hybrid imaging modality that is noninvasive, nonionizing, with high sensitivity, 
satisfactory imaging depth for the prostate and good temporal and spatial resolution. PAT is a 
natural  complement  to  existing  ultrasonography  and  should  enlarge  the  scope  of  US  in 
diagnostic  imaging  and  therapeutic  monitoring  of  prostate  cancer  by  providing  additional 
information. Numerous previous studies have demonstrated that new blood vessel growth, 
termed angiogenesis, is essential for growth and metastasis of most solid tumors including 
prostate  cancer.  PAT,  based  on  its  high  sensitivity  to  blood,  may  evaluate  tumor-related 
vascular distortion, including both angiogenesis and dilation of blood vessels in cancerous 
tissues [15]. The increased blood volume in tumor regions, a functional hallmark of prostate 
cancer, might be detected and localized reliably by PAT with high optical contrast and high 
spatial resolution. When working with multiple laser wavelengths, PAT may also quantify the 
inadequate oxygen delivery, i.e. profound hypoxia and oxidative stress, in local tumors as 
another functional hallmark of prostate cancer [16,17]. When PAT is realized based on a 
commercial US unit [18–22], the dual-modality imaging capability will allow inexpensive, 
nonionizing and noninvasive visualization of both acoustic and optical tissue properties as 
well as physiological biomarkers of prostate cancer including blood flow by Doppler US and 
blood  volume  and  oxygenation  by  PAT.  With  the  comprehensive  diagnostic  information 
presented  by  a  combined  US  and  PAT  prostate  imaging  system,  more  accurate 
characterization of prostate cancer could be achieved than by using conventional transrectal 
US alone. 
2. Method 
A high-speed PAT data acquisition system was assembled using a commercial US scanner 
working with a P4-1 phased array (z.one, ZONARE Medical Systems, Inc.), as shown in  
Fig. 1. A Nd:YAG laser (Powerlite, Continuum) pumped dye laser (ND6000, Continuum) 
provides laser pulses with a repetition rate of 10 Hz, wavelength of 710 nm, and a pulse length 
of  5  ns.  The  laser-generated  photoacoustic  signals  are  acquired  by  the  US  unit; 
synchronization between the US receive cycle and the laser firing is achieved using a frame-
trigger signal tapped into the ultrasonic probe connector. To acquire a 2D PAT image in a 
prostate, the US unit operates in receive-only mode (with the transmitter turned off) at a frame 
rate that matches the 10 Hz repetition rate of the laser; while working on the US mode with 
the transmitter turned on, B-mode US images of the same imaging plane in the prostate can be 
taken. For command and control, a serial (RS-232) data link is set up between the US unit and 
an external PC. Through a Tera Term console that supports serial communications between 
the US unit and the PC, the user runs a command script that sends imaging control parameters 
to the US unit, including the start of data acquisition, transmitter  on/off, transmit delays, 
acquisition frame rate, time-gain compensation, and demodulation frequency. 
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Fig. 1. Schematic of the experimental system for PAT and US imaging of a canine prostate in 
vivo. 
For each laser pulse, 64 channels of 16-bit in-phase quadrature (I/Q) data are acquired 
from a selectable 64-element sub-aperture of the array. Therefore, only 2 laser pulses are 
required for the acquisition of a complete 128-element data set for a 2D PAT image, at an 
effective full frame rate acquisition of 5 Hz. If needed, repeat acquisitions are made to support 
coherent  data  averaging  for  improved  signal-to-noise  ratios  (SNR).  Once  the  I/Q  data 
including both reconstructed and channel data are captured in the cine buffer, they can be 
transferred as binary raw data files to an external USB storage device. On the PC, a MATLAB 
tool is used to extract the raw I/Q data and associated imaging parameters from binary data 
files. The RF data from the 64 or 128 elements are then processed using a standard ultrasound 
dynamic receive focusing algorithm to reconstruct a PAT image. 
Before the experiment on canine prostates in vivo, the lateral and axial resolution of this 
PAT system were evaluated by imaging a micro-flow vessel phantom made from a transparent 
soft tube (I.D. 0.5 mm, Cole-Parmer) filled with fresh canine blood. With the orientation of 
the vessel orthogonal to the transducer array, a point object was formed in the 2D B-scan 
plane when the vessel was illuminated by a narrow laser beam. The delay curve in Fig. 2(A) 
shows the I/Q data of received photoacoustic signals from the point object acquired by the 128 
array  elements.  This  signal  was  induced  by  a  single  laser  pulse  with  an  incident  energy 
density within the ANSI safety limit [23]. The fast Fourier transform (FFT) of the RF data 
converted from the I/Q data indicated that the imaging system working with the P4-1 array 
was sensitive in the spectrum of 1.5-4.2 MHz with a fairly broad 6 dB receiving bandwidth 
of 94%. Using the standard ultrasound dynamic receive focusing algorithm, a 2D PAT image 
of the point object was reconstructed, as shown in Fig. 2(B). By studying the image intensities 
through  the  center  of  the  point  object  along  the  axial  (depth)  and  the  lateral  (azimuthal) 
directions  [as  shown  in  Figs.  2(C)  and  2(D)  respectively],  the  6  dB  axial  and  lateral 
resolution achieved by this system were 0.65 mm and 0.52 mm, respectively, at a depth of 20 
mm where the azimuthal f-number was approximately 0.7. 
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Fig. 2. (A) 128-channel I/Q data from a point object. (B) Reconstructed 2D PAT image of the 
point object. (C) System axial resolution. (D) System lateral resolution. (E) Photograph of a gel 
phantom with two artificial vessels embedded. (F) 2D gray scale US image of the phantom (G) 
2D PAT image of the phantom along the same plane as in US image in (F). 
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a  micro-flow  vessel  phantom  with  known  vascular  structure  was  imaged.  As  shown  in  
Fig. 2(E), two vessels made with the same transparent soft tubing (I.D. 0.5 mm) as above, 
filled with fresh canine blood, were embedded in the same 2D plane in a block of porcine gel. 
First, a 2D gray scale pulse echo US image of this phantom was taken, as shown in Fig. 2(F). 
The  apparent poor  axial resolution  is  caused  by  reverberations  in  the  tube.  Then  without 
moving the sample or the probe, the system shifted to PAT mode with the US transmitter 
turned off. When illuminated by laser light at 850-nm wavelength with incident light fluence 
within the ANSI safety limit, a PAT image of the same 2D cross-section was taken, as shown 
in Fig. 2(G). The B-scan PAT image was reconstructed using the signals from the full 128 
elements without apodization. Based on the strong optical absorption contrast between the 
canine  blood  and  the  background  gel,  the  two  vessels  were  imaged  with  satisfactory 
continuity, resulting in a good match with the sample photograph. 
3. Animal model 
To  examine  the  performance  of  this  system  for  PAT  and  US  dual-modality  imaging  of 
prostate, scanning of canine prostates in vivo was conducted. The laboratory animal protocol 
for this work was approved by the UCUCA of the University of Michigan. All dogs were pre-
anesthitized  by  an  IM  injection  of  Acepromazine,  administered  thiopental  to  effect  for 
anesthesia induction, intubated, and full anesthesia maintained by inhalation of Isoflurane. 
The animal was instrumented with a pulse-oximeter to measure pulse and SPO2, ECG, core 
body temperature and respiration during the entire experiment. The suprapubic area of all 
animals was shaved. Entry to the abdomen was through a lower midline vertical incision 
approximately  30  cm  in  length.  The  bladder  was  identified,  atraumatically  mobilized  and 
retracted cephalad to facilitate exposure of the underlying prostate. 
To validate the feasibility of PAT for future noninvasive transrectal imaging of prostate 
cancer, this experiment focused on the ability of PAT, with incident NIR energy within the 
ANSI  safety  limit,  to  capture  blood-rich  lesions  in  subsurface  prostate  in  vivo  through 
reasonable optical and ultrasonic path lengths. To mimic the characteristics of tumor, pseudo 
lesions were induced by intraprostatic injection of varying amounts of fresh canine blood, in 
light of the increased angiogenic nature of prostate cancer lesions and thus relatively increased 
hemoglobin levels. Blood collected from the same dog was injected through a plastic canula 
inserted to the midline lateral surface of one lobe of the exposed prostate. 2D B-scan PAT and 
US imaging of a cross-section in the X-Y plane through the lesion were conducted. In order to 
guarantee that the lesion is within the imaged cross-section, gray scale US scan over the 
whole prostate was performed first to locate the end of the inserted canula. The laser beam, 
after being expanded and homogenized, illuminated along the Z-axis covering a round area 
with a diameter of 4 cm. With a total input energy of 100 mJ, the incident light energy density 
on the tissue was approximately 8 mJ/cm
2, well below the ANSI safety limit. In order to 
examine the ability of PAT to image deep prostate lesions through the rectal wall, a slab of 
fresh pork muscle (15 mm thick) was also used to cover the surface of the exposed prostate, 
mimicking the connective tissue between prostate and rectum. Therefore, since the depth of 
the lesion in the prostate was about 10 mm, the optical and ultrasound path lengths were both 
approximately 25 mm. 
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Fig. 3. In vivo PAT and US dual-modality imaging of a canine prostate with a subsurface lesion 
induced. Gray scale US images of the prostate acquired (A) before and (B) after the generation 
of the lesion (0.1 mL of injected blood). The red arrow indicates the plastic canula inserted into 
the  prostate  for  the  injection  of  blood.  The  yellow  indicates  the  urethra.  (C)  Anatomical 
photograph of the imaged cross-section in the prostate with the lesion marked. PAT images of 
the prostate right lobe acquired (D) before and (E) after the generation of the lesion (0.1 mL of 
injected blood), where the image intensities are demonstrated with an image color bar. The 
PAT imaging plane is the same as that in US images, where the reconstructed area is indicated 
with  the  dashed  rectangles  in  the  US  images  in  (A)  and  (B).  In  (F)-(I),  PAT  images  are 
superimposed on the US image in (B). (F) was acquired before the generation of the lesion; 
(G), (H) and (I) were acquired after three injections of blood, where the total blood volumes in 
the lesion were 0.025 mL, 0.05 mL and 0.1 mL, respectively. The area of the lesion is marked 
with a dotted rectangle in each image. 
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Before generation of the pseudo lesion, US and PAT images of the canine prostate were taken, 
as  shown  in  Figs.  3(A)  and  3(D).  In  the  gray-scale  B-mode  US  images,  morphological 
features of the prostate including the boundary and the urethra (yellow arrow), as well as the 
plastic canula (red arrow) inserted into the prostate for the generation of the lesion, can be 
clearly  recognized.  During  the  experiment,  three  local  injections  of  canine  blood  were 
performed through the plastic canula without moving the prostate or the US probe. The doses 
of  the  three  injections were  0.025,  0.025 and 0.050  mL  respectively.  Therefore,  the  total 
additional blood volumes in the lesion area after the three injections were 0.025, 0.05 and 0.1 
mL (i.e. 1:2:4). After each injection, US and PAT images of the same cross-section were 
taken. Comparing the two US images taken before and after the generation of the lesion, no 
obvious change can be noticed in the lesion area due to the limited contrast of US in imaging 
small volumes of static blood. Because of the high sensitivity of PAT for blood content, the 
signal enhancement in the lesion area in Fig. 3(E) (marked with a dotted rectangle) can be 
seen clearly in comparision with Fig. 3(D). In Fig. 3(F)–3(I), four PAT images taken before 
and after the three injections respectively are superimposed on the gray-scale US image in 
Fig.  3(B),  where  a  color  bar  is  given  to  present  the  PAT  image  intensity.  With  the 
morphological features presented by the US image, we can see that the signal enhancement in 
each  PAT  image  is  around  the  tip  of  the  plastic  canula,  i.e.  in  the  generated  lesion.  To 
quantitatively evaluate the signal enhancement as a function of the injected blood volume, we 
have computed the mean intensity for all the pixels in the dotted rectangle in each PAT image. 
The mean intensity values in the lesion area are 0.25, 0.35, 0.47 and 0.59 for the results in 
Figs. 3(F)–3(I) respectively. Therefore, the signal increases over no injections are 0.10, 0.22 
and 0.34, respectively, after the three injections. The ratio among three increases are 1:2.2:3.4, 
close to the ratio among the total introduced blood volumes after the three injections (i.e. 
1:2:4). The good match between the photoacoustic signal enhancement and the total injected 
blood volume of the lesion suggests that PAT, with its high optical contrast and good spatial 
resolution, may not only visualize local prostate lesions in a noninvasive manner but also 
characterize the functional parameters in lesions such as total hemoglobin concentration (i.e. 
blood volume). 
5. Discussion 
In PAT, the ability to achieve high depth of imaging is primarily a function of total laser pulse 
energy of short enough duration and illuminating the tissues over a large enough area to 
remain below the ANSI safety limit. For tomographic photoacoustic imaging of deep tissue, 
the ability to achieve high image quality including good spatial resolution and less artifacts is 
strongly  dependent  on  the  total  view  angle  (or  solid  angle  in  3D  imaging)  in  detecting 
photoacoustic  signals,  even  though  some  advanced  reconstruction  algorithms  have  been 
explored for improved performance in limited-viewing angle situations [24–28]. To study the 
effect of different detection view angle on the image quality, ex vivo imaging of a canine 
prostate  was  conducted  through  a  circular  scan  of  a  single  element  transducer  (V312, 
Panametrics).  The  geometry  of  signal  detection  from  the  prostate  was  similar  to  that 
developed  for  imaging  of  small  animal  brains  [29,30].  Briefly,  the  cylindrically  focused 
transducer (unfocused in the imaging plane) with a center frequency at 10 MHz and a 6 dB 
bandwidth of 130% collected signals from the prostate through a circular scan around the 
imaged cross-section, while the laser beam illuminated the whole prostate with an incident 
direction orthogonal to the imaging plane. To cover a 2π view angle, 160 points around the 
prostate  were  acquired  at  2.25  degree  increments.  Figure  4(B)  presents  the  2D  image 
reconstructed using the signals received from a full 2π angular range. Based on the intrinsic 
optical contrast among soft tissues, morphological features in the prostate, including the area 
of periurethral gland (i.e. the zone surrounding the urethra) and the gap between the left and 
right lobes, were imaged with satisfactory resolution and minimal artifacts. When the view 
angle for reconstructed signals was decreased, the artifact in the reconstructed image was 
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detection view angles were 180, 90, 60 and 30 degrees, respectively. 
 
Fig. 4. Ex vivo 2D PAT of a canine prostate. (A) Anatomical photograph of the imaged cross-
section. (B)-(F) Tomographic images acquired with detection view angles of 360, 180, 90, 60 
and 30 degrees, respectively. 
Due  to  the  small  aperture  of  conventional  endorectal  probes,  PAT  of  prostate  when 
conducted in a noninvasive transrectal manner can only be achieved with a limited-viewing 
angle for signal detection (normally less than 30 degree). Therefore in this study, instead of 
using a conventional endorectal probe that is commonly used in endoscopic US evaluation of 
the prostate [31], we have examined the feasibility of PAT for prostate using a phased array 
that has a larger footprint (28.2-mm long) and enables a comparatively larger view angle for 
the detection of photoacoustic signals from subsurface lesions (about 60 degree at a depth of 
25 mm). This phased array with 128 elements works in a relatively low frequency range of  
1-4 MHz that also facilitates more sensitive detection of large-scale, light-absorbing objects 
such  as  cancerous  lesions  in  the  prostate.  Although  scanning  with  limited-viewing  angle 
cannot be avoided for transrectal imaging, a specially designed endorectal probe with a longer 
footprint could be employed and should contribute to the improvement of image quality and 
quick acceptance of PAT in the clinic. A specially designed photoacoustic endorectal probe 
should also enable better receive sensitivity over a broader bandwidth, both of which are 
essential  to  achieve  satisfactory  performance  for  future  clinical  management  of  prostate 
cancer. Another concern of clinical adaptation of PAT to prostate imaging is the delivery of 
laser light noninvasively. The illumination of the prostate could be realized via the rectum 
through an optical fiber array integrated in the rectal probe, similar to the design employed in 
trans-rectal near-infrared optical tomography of the prostate [14]. 
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original imaging functions. This allowed dual-modality imaging of a canine prostate offering 
both optical and ultrasonic information. The development of PAT for prostate cancer should 
be  accelerated  by  taking  advantage  of  state-of-the-art  commercial  US  image  processing, 
management and display technologies. For example, PAT of canine prostates in this study was 
achieved at a fast speed by acquiring data from the 64 parallel ultrasound channels each with 
commercial-grade receiver sensitivity and noise figures. These and other imaging findings, 
when derived from a commercially available US system, should be more easily reproduced 
between laboratories, and introduced more quickly into the clinic. In comparison with PAT, 
US is a more established imaging modality for prostate cancer. Therefore, interpretation of US 
images of a prostate specimen may help guide the PAT procedure and interpretation. As an 
example,  the  morphological  features  including  the  organ  boundary  and  the  urethra  as 
presented by the gray-scale US images has helped to identify the accurate location of the 
lesion visualized by PAT. In  the future, tissue acoustic information provided by US,  e.g. 
acoustic attenuation and speed of sound, may also be used to improve the reconstruction of 
PAT images, which may elevate the accuracy in quantitative imaging of prostate tissue optical 
properties and hemodynamic parameters. 
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